ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says.

December 9, 2005

Concept Approved For New Quality Assurance Center

May 14, 1982

Study Finds Nearly Two-Thirds Of Children Return to Hospital Following Stem Cell Transplant

April 26, 2013